Kevin Ballinger
Director/Miembro de la Junta en SILK ROAD MEDICAL, INC .
Fortuna: 884 433 $ al 30/04/2024
Cargos activos de Kevin Ballinger
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SILK ROAD MEDICAL, INC | Director/Miembro de la Junta | 03/12/2020 | - |
| Independent Dir/Board Member | 03/12/2020 | - | |
| SHOCKWAVE MEDICAL, INC. | Director/Miembro de la Junta | 16/05/2023 | - |
Historial de carrera de Kevin Ballinger
Antiguos cargos conocidos de Kevin Ballinger.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Aldevron LLC
 Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Director Ejecutivo | 13/07/2020 | 11/09/2023 |
| Presidente | 13/07/2020 | 11/09/2023 | |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - | 03/07/2020 |
Formación de Kevin Ballinger.
| Michigan Technological University | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| SILK ROAD MEDICAL, INC | Health Technology |
| SHOCKWAVE MEDICAL, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Health Technology |
- Bolsa de valores
- Insiders
- Kevin Ballinger
- Experiencia
